SEC Form 4 · accession 0001144204-15-033987
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ian Johnson
Officer — President and CEO · Director
Period of report
May 27, 2015
Accepted (ET)
May 28, 2015 · 2:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 27, 2015 | P | 10,000 | $4.6458 | A | 595,144 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $4.53 to $4.74, inclusive. The reporting person undertakes to provide to Alliqua BioMedical, Inc., any security holder of Alliqua BioMedical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.